Company	Price	Valuation					Profitability					Cash & leverage					Quality				Rating
		P/E	P/B	P/S	EV / EBITDA	DCF upside	Gross margin	Operating margin	Net margin	ROE	ROIC	FCF yield	Debt / equity	Net debt / EBITDA	Interest coverage	Current ratio	Dividend yield	Piotroski (0-9)	Altman Z	Rating score (1-5)
GUJTHEM.NSthis companyGujarat Themis Biosyn Limited	₹379.65	53.14×	8.62×	14.96×	33.86×	-93.5%	46.4%	37.8%	28.2%	16.2%	10.3%	-5.2%	0.56×	2.04×	21.23×	1.12×	0.3%	—	—	1	D+
AARTIDRUGS.NSAarti Drugs Limited	₹499.75	14.97×	1.88×	1.14×	11.19×	-76.9%	29.2%	9.4%	7.6%	12.6%	10.1%	1.7%	0.37×	1.82×	7.19×	1.59×	0.6%	4	3.46	2	C
ANUHPHR.NSAnuh Pharma Limited	₹82.78	16.37×	1.91×	0.87×	10.04×	12.6%	17.4%	6.5%	5.3%	11.7%	10.8%	-1.6%	0×	-0.12×	106.58×	2.22×	2.2%	—	—	2	C
GUFICBIO.NSGufic Biosciences Limited	₹474.35	42.78×	4.13×	2.91×	19.97×	-117.2%	36.0%	12.8%	6.8%	9.7%	8.1%	-0.7%	0.61×	2.13×	3.29×	1.55×	0.0%	6	—	1	C-
HIKAL.NSHikal Limited	₹225.40	-37.14×	1.51×	1.06×	16.85×	-107.8%	30.2%	3.3%	-2.8%	-4.1%	1.8%	4.9%	0.57×	4.57×	0.91×	1.3×	0.7%	3	—	1	C-
KOPRAN.NSKopran Limited	₹259.76	20.27×	0.98×	0.77×	10.71×	-111.9%	23.4%	8.9%	3.8%	4.9%	6.5%	-2.0%	0.29×	2.33×	5.77×	1.51×	2.8%	5	—	3	B-
Peer median	—	16.37×	1.88×	1.06×	11.19×	-107.8%	29.2%	8.9%	5.3%	9.7%	8.1%	-0.7%	0.37×	2.13×	5.77×	1.55×	0.7%	5	3.46	2	—